Edwards Lifesciences Corp (EW)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 9,998,400 | 6,650,000 | 5,806,700 | 5,835,900 | 4,574,300 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $9,998,400K
= 0.00
The debt-to-equity ratio of Edwards Lifesciences Corp has consistently been reported as 0.00 for the years ending on December 31, 2020 through December 31, 2024. This indicates that the company has no long-term debt compared to its equity during these periods. A debt-to-equity ratio of 0.00 typically suggests that the company is financing its operations mostly through equity rather than debt, which may imply lower financial risk and a strong financial position. However, it's important to note that a very low debt-to-equity ratio could also mean missed opportunities for leveraging debt for potential growth or tax benefits. Overall, the consistent 0.00 debt-to-equity ratio for Edwards Lifesciences Corp reflects a prudent and conservative financial strategy with limited reliance on debt financing.
Peer comparison
Dec 31, 2024